Journal article icon

Journal article

Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial

Abstract:

Background

There has been a recent steep growth in platelet-rich plasma (PRP) use for musculoskeletal conditions, but findings from high quality clinical trial data are lacking in the literature. Here, we describe the statistical analysis plan (SAP) for the Platelet-rich plasma in Achilles Tendon Healing 2 (PATH-2) trial.

Methods

PATH-2 is a pragmatic, parallel-group, multi-centre, double-blinded, randomised, placebo-controlled, superiority trial. The study aims t...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1186/s13063-018-2840-z

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Role:
Author
ORCID:
0000-0002-1711-9310
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Subgroup:
Botnar Research Centre
Role:
Author
ORCID:
0000-0002-5566-0925
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Subgroup:
Botnar Research Centre
Oxford college:
Wadham College; Wadham College
Role:
Author
ORCID:
0000-0003-4349-7195
Expand authors...
Publisher:
BioMed Central Publisher's website
Journal:
Trials Journal website
Volume:
19
Issue:
1
Pages:
464
Publication date:
2018-08-29
Acceptance date:
2018-08-04
DOI:
EISSN:
1745-6215
ISSN:
1745-6215
Pubs id:
pubs:894253
URN:
uri:c22006d2-a4e4-4e2d-908e-6c0c806c36b9
UUID:
uuid:c22006d2-a4e4-4e2d-908e-6c0c806c36b9
Local pid:
pubs:894253

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP